KBC Group NV Purchases 3,334 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...
Myriad Uranium Enters into Option to Acquire 100% of the Red Basin Uranium Project in New Mexico, USA
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has ...
Myriad Genetics, INTERLINK Partner To Enhance Access To Hereditary Cancer Testing
Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...
Valentine event to support Warrick Humane Society
The “Mutts at Myriad” event will be held Sunday, February 16 from 12 p.m. to 3 p.m. at Myriad Brewing Company in Newburgh.
Pharmabiz3d
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...
Myriad Genetics management to meet with BTIG
Group meeting and tour of company headquarters with CEO Diaz, COO Raha and CFO Leffler in Salt Lake City, Utah on February 10 hosted by ...
manilatimes4d
Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...